- $272.84m
- $265.83m
- $47.27m
- 66
- 31
- 89
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34.7 | 24.1 | 29.5 | 38 | 47.3 |
Cost of Revenue | |||||
Gross Profit | 19.2 | 9.3 | 14.7 | 21 | 24.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 28.6 | 32.5 | 32.2 | 37.7 | 47.4 |
Operating Profit | 6.1 | -8.34 | -2.74 | 0.344 | -0.167 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.54 | -8.25 | -2.71 | 1.14 | 2.36 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.45 | -9.14 | -2.72 | 1.03 | 6.46 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.45 | -9.14 | -2.72 | 1.03 | 6.46 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.45 | -9.14 | -2.72 | 1.03 | 6.46 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.137 | -0.18 | -0.053 | 0.019 | 0.119 |